The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure
Authors:
- Michael ChristiansenMCMichael Christiansen
- Julia S. JohansenJJJulia S. Johansen
- Lars KøberLKLars Køber
- Christian Torp-PetersenCTChristian Torp-Petersen
- Jens KastrupJKJens Kastrup
- 1 June 2012
- journal article
- Published by Elsevier in Immunobiology
- Vol. 217 (6) , 652-656
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of GlioblastomaJournal of Biological Chemistry, 2011
- Increased levels of the calcification marker Matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart diseaseCardiovascular Diabetology, 2010
- High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR TrialScandinavian Journal of Clinical and Laboratory Investigation, 2010
- Plasma YKL-40 levels are elevated in patients with chronic heart failureScandinavian Cardiovascular Journal, 2009
- High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery diseaseEuropean Heart Journal, 2009
- YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of AlbuminuriaDiabetes Care, 2009
- Concentrations of C-Reactive Protein and B-Type Natriuretic Peptide 30 Days after Acute Coronary Syndromes Independently Predict Hospitalization for Heart Failure and Cardiovascular DeathClinical Chemistry, 2009
- Usefulness of C-Reactive Protein and Left Ventricular Diastolic Performance for Prognosis in Patients With Left Ventricular Systolic Heart FailureThe American Journal of Cardiology, 2008
- B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are comparably useful for disease monitoring in heart failureInternational Journal of Cardiology, 2006
- Regulation of YKL‐40 expression during genotoxic or microenvironmental stress in human glioblastoma cellsCancer Science, 2005